These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 21030527

  • 1. Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens.
    Laosinchai-Wolf W, Ye F, Tran V, Yang Z, White R, Bloom K, Choppa P, Labourier E.
    J Clin Pathol; 2011 Jan; 64(1):30-6. PubMed ID: 21030527
    [Abstract] [Full Text] [Related]

  • 2. Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay.
    Chang YS, Er TK, Lu HC, Yeh KT, Chang JG.
    Clin Chim Acta; 2014 Sep 25; 436():169-75. PubMed ID: 24863805
    [Abstract] [Full Text] [Related]

  • 3. Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma.
    Lee S, Brophy VH, Cao J, Velez M, Hoeppner C, Soviero S, Lawrence HJ.
    Virchows Arch; 2012 Feb 25; 460(2):141-9. PubMed ID: 22173329
    [Abstract] [Full Text] [Related]

  • 4. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
    Heideman DA, Lurkin I, Doeleman M, Smit EF, Verheul HM, Meijer GA, Snijders PJ, Thunnissen E, Zwarthoff EC.
    J Mol Diagn; 2012 Feb 25; 14(3):247-55. PubMed ID: 22425762
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sensitive detection of KRAS mutations in archived formalin-fixed paraffin-embedded tissue using mutant-enriched PCR and reverse-hybridization.
    Ausch C, Buxhofer-Ausch V, Oberkanins C, Holzer B, Minai-Pour M, Jahn S, Dandachi N, Zeillinger R, Kriegshäuser G.
    J Mol Diagn; 2009 Nov 25; 11(6):508-13. PubMed ID: 19797612
    [Abstract] [Full Text] [Related]

  • 8. High sensitivity of reverse-hybridization methodology in the detection of KRAS mutations from formalin-fixed paraffin-embedded colorectal cancer samples.
    De Miglio MR, Mura A, Uras MG, Manca A, Contini M, Murgia L, Zinellu A, Sotgia S, Carru C, Massarelli G, Cossu-Rocca P.
    Diagn Mol Pathol; 2010 Dec 25; 19(4):201-8. PubMed ID: 21052001
    [Abstract] [Full Text] [Related]

  • 9. Validation of a Multiplex Allele-Specific Polymerase Chain Reaction Assay for Detection of KRAS Gene Mutations in Formalin-Fixed, Paraffin-Embedded Tissues from Colorectal Cancer Patients.
    Seekhuntod S, Thavarungkul P, Chaichanawongsaroj N.
    PLoS One; 2016 Dec 25; 11(1):e0147672. PubMed ID: 26812617
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues.
    Okayama N, Nishioka M, Hazama S, Sakai K, Suehiro Y, Maekawa M, Sakamoto J, Iwamoto S, Kato T, Mishima H, Oka M, Hinoda Y.
    Jpn J Clin Oncol; 2011 Feb 25; 41(2):165-71. PubMed ID: 20926413
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Heterogeneity of colorectal cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technology.
    Perez K, Walsh R, Brilliant K, Noble L, Yakirevich E, Breese V, Jackson C, Chatterjee D, Pricolo V, Roth L, Shah N, Cataldo T, Safran H, Hixson D, Quesenberry P.
    Exp Mol Pathol; 2013 Aug 25; 95(1):74-82. PubMed ID: 23528430
    [Abstract] [Full Text] [Related]

  • 16. KRAS gene mutation in a series of unselected colorectal carcinoma patients with prognostic morphological correlations: a pyrosequencing method improved by nested PCR.
    de Macêdo MP, de Melo FM, Lisboa BC, Andrade LD, de Souza Begnami MD, Junior SA, Ribeiro HS, Soares FA, Carraro DM, da Cunha IW.
    Exp Mol Pathol; 2015 Jun 25; 98(3):563-7. PubMed ID: 25835782
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A novel liquidchip platform for simultaneous detection of 70 alleles of DNA somatic mutations on EGFR, KRAS, BRAF and PIK3CA from formalin-fixed and paraffin-embedded slides containing tumor tissue.
    Li G, Luo X, He J, Zhu Z, Yu G, Qin H, Zeng T, Liu Z, Wu S, Xu J, Ren-Heidenreich L.
    Clin Chem Lab Med; 2011 Feb 25; 49(2):191-5. PubMed ID: 21118047
    [Abstract] [Full Text] [Related]

  • 19. Optimization of routine KRAS mutation PCR-based testing procedure for rational individualized first-line-targeted therapy selection in metastatic colorectal cancer.
    Chretien AS, Harlé A, Meyer-Lefebvre M, Rouyer M, Husson M, Ramacci C, Harter V, Genin P, Leroux A, Merlin JL.
    Cancer Med; 2013 Feb 25; 2(1):11-20. PubMed ID: 24133623
    [Abstract] [Full Text] [Related]

  • 20. Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls.
    Lamy A, Blanchard F, Le Pessot F, Sesboüé R, Di Fiore F, Bossut J, Fiant E, Frébourg T, Sabourin JC.
    Mod Pathol; 2011 Aug 25; 24(8):1090-100. PubMed ID: 21516079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.